Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-24-007123

Director bought 476,190 shares at $21.00 ($9,999,990)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2024-01-22 Purchase +476,190 $21.00 $9,999,990 1,839,954 I
Open-market purchases · 476,190 sh · avg $21.00 · $9,999,990
Loading xslF345X05/ownership.xml…